Skip to content
← Back to this collection

PUBLICATIONS · 31425966

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2019 Sep
First author
Yang Q

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Yang Q
      type
      Author
    2. name
      Cao SM
      type
      Author
    3. name
      Guo L
      type
      Author
    4. name
      Hua YJ
      type
      Author
    5. name
      Huang PY
      type
      Author
    6. name
      Zhang XL
      type
      Author
    7. name
      Lin M
      type
      Author
    8. name
      You R
      type
      Author
    9. name
      Zou X
      type
      Author
    10. name
      Liu YP
      type
      Author
    11. name
      Xie YL
      type
      Author
    12. name
      Wang ZQ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Yang Q
      type
      Author
    2. name
      Cao SM
      type
      Author
    3. name
      Guo L
      type
      Author
    4. name
      Hua YJ
      type
      Author
    5. name
      Huang PY
      type
      Author
    6. name
      Zhang XL
      type
      Author
    7. name
      Lin M
      type
      Author
    8. name
      You R
      type
      Author
    9. name
      Zou X
      type
      Author
    10. name
      Liu YP
      type
      Author
    11. name
      Xie YL
      type
      Author
    12. name
      Wang ZQ
      type
      Author
    bibliography ids
    1. nci-bib-c6c29ddc7fbd21be834f0d7b
    book metadata
    content sha256
    0f32ce423f8d1c32b5685dbd30c7b054d673bf086ac769f86041c53e277557f3
    document type
    citation
    dois
    1. 10.1016/j.ejca.2019.07.007
    electronic publication date
    display
    2019 Aug 16
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31425966
    immutable id
    pubmed:31425966@0f32ce423f8d1c32b5685dbd30c7b054d673bf086ac769f86041c53e277557f3
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    87-96
    volume
    119
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31425966
      provenance
      batch id
      23ffe1e2a9e160b6dca0
      provider
      NCBI PubMed ESummary
      record sha256
      268ad1fdfe75d9142ba763f7b00b71088f9242d8573009df01450f51fc33c888
      response sha256
      d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
      retrieved at
      2026-09-09T23:47:44.690737+00:00
      publication date
      display
      2019 Sep
      precision
      month
      year
      2019
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31425966/
      title
      Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.

      Preserved source evidence · Not medical advice